Apollomics (APLMW) Competitors $0.01 0.00 (-5.61%) As of 01/17/2025 09:30 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrends APLMW vs. ATNFW, SXTPW, DRTSW, WENAW, BCTXW, CDIOW, CTCXW, CELUW, CEROW, and CINGWShould you be buying Apollomics stock or one of its competitors? The main competitors of Apollomics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), CERo Therapeutics (CEROW), and Cingulate (CINGW). These companies are all part of the "biotechnology" industry. Apollomics vs. 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical Anew Medical BriaCell Therapeutics Cardio Diagnostics Carmell Celularity CERo Therapeutics Cingulate 180 Life Sciences (NASDAQ:ATNFW) and Apollomics (NASDAQ:APLMW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, community ranking, institutional ownership and dividends. Which has higher valuation & earnings, ATNFW or APLMW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/AApollomicsN/AN/AN/AN/AN/A Does the media favor ATNFW or APLMW? In the previous week, Apollomics had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 1 mentions for Apollomics and 0 mentions for 180 Life Sciences. Apollomics' average media sentiment score of 1.00 beat 180 Life Sciences' score of 0.00 indicating that Apollomics is being referred to more favorably in the news media. Company Overall Sentiment 180 Life Sciences Neutral Apollomics Positive Does the MarketBeat Community prefer ATNFW or APLMW? 180 Life Sciences and Apollomics both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/AApollomicsN/AN/A Is ATNFW or APLMW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Apollomics N/A N/A N/A SummaryApollomics beats 180 Life Sciences on 2 of the 2 factors compared between the two stocks. Get Apollomics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLMW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APLMW vs. The Competition Export to ExcelMetricApollomicsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$176.09M$5.23B$8.94BDividend YieldN/A3.64%5.13%4.04%P/E RatioN/A133.2058.7713.30Price / SalesN/A18,796.851,253.7679.32Price / CashN/A13.0143.8235.97Price / BookN/A9.535.324.79Net IncomeN/A-$20.89M$122.69M$225.00M7 Day PerformanceN/A-0.62%-0.17%1.52%1 Month PerformanceN/A1.66%3.49%4.88%1 Year PerformanceN/A130.31%25.79%20.12% Apollomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APLMWApollomicsN/A$0.01-5.6%N/A-65.8%$0.00N/A0.0059Positive NewsGap DownATNFW180 Life SciencesN/A$0.01+2.9%N/A+80.0%$0.00N/A0.007Positive NewsGap DownHigh Trading VolumeSXTPW60 Degrees PharmaceuticalsN/A$0.03+7.4%N/AN/A$0.00$502,409.000.002Positive NewsDRTSWAlpha Tau MedicalN/A$0.30+57.9%N/A+5.1%$0.00N/A0.0080News CoveragePositive NewsHigh Trading VolumeWENAWAnew MedicalN/A$0.04-0.3%N/AN/A$0.00N/A0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.24-29.9%N/A-93.5%$0.00N/A0.008Short Interest ↑News CoveragePositive NewsGap DownCDIOWCardio DiagnosticsN/A$0.09-2.6%N/A-69.8%$0.00$35,688.000.007CTCXWCarmellN/A$0.06+19.6%N/A-75.0%$0.00$32,839.000.009Positive NewsGap UpCELUWCelularityN/A$0.02+1.0%N/AN/A$0.00$48.20M0.00220Positive NewsCEROWCERo TherapeuticsN/A$0.01+54.4%N/AN/A$0.00N/A0.008Short Interest ↑Gap DownCINGWCingulateN/A$0.07+5.8%N/A+396.3%$0.00N/A0.0020Positive NewsGap Up Related Companies and Tools Related Companies ATNFW Alternatives SXTPW Alternatives DRTSW Alternatives WENAW Alternatives BCTXW Alternatives CDIOW Alternatives CTCXW Alternatives CELUW Alternatives CEROW Alternatives CINGW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:APLMW) was last updated on 1/19/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apollomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apollomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
